FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976706183> ?p ?o ?g. }

• W1976706183 endingPage "1509" @default.
• W1976706183 startingPage "1502" @default.
• W1976706183 abstract "In a previous biomarker discovery project using gene-expression profiling we identified Serpin B3 (SB3) as a predictor of resistance to platinum doublet chemotherapy (PtC) in non-small-cell lung cancer (NSCLC). This independent prospective study was designed to confirm the predictive utility of SB3.SB3 immunohistochemistry was scored by previously validated criteria (score 0 = negative, score 1 = 1%-10% tumor cells positive, score 2 = 11%-50% tumor cells positive, and score 3 = >50% tumor cell positive) in 197 patients with stage IV NSCLC treated with PtC. This provided 80% power to detect a median survival increase from 150 days in patients with an SB3 immunohistochemistry score of 2 or more to 300 days in those with an SB3 score of 0 or 1.Thirty-six percent of NSCLCs stained positive for SB3. Median survival for SB3 negative/score 0 was 332 days, SB3 positive/score 1 was 268 days, and SB3 positive/score 2 or 3 was 120 days (p = 0.004). Cox proportional hazards analysis demonstrated that SB3 positivity is an independent predictor of survival (hazard ratio = 1.87; 95% confidence interval, 1.29-2.71; p = 0.001).The disease control rate in SB3 score 0, 1 = 65%, and score of 2 or more = 20 % (p = 0.002), with median survival 306 days (score 0, 1) versus 120 days (score ≥ 2, hazard ratio= 1.71; 95% confidence interval. 1.14-3.10; p = 0.002).SB3-positive immunohistochemistry score of 2 or more (>10% tumor cells positive) identifies a subgroup of patients with stage IV NSCLC who have a poor survival (median 120 days) when treated with PtC, similar to that estimated for untreated or chemo-refractory stage IV NSCLC. Further prospective qualification using biospecimens from randomized studies is needed, but SB3 seems to be a useful biomarker that identifies a highly resistant subgroup in whom PtC should be avoided." @default.
• W1976706183 created "2016-06-24" @default.
• W1976706183 creator A5038925845 @default.
• W1976706183 creator A5045865889 @default.
• W1976706183 creator A5049882275 @default.
• W1976706183 creator A5051588878 @default.
• W1976706183 creator A5055057910 @default.
• W1976706183 creator A5056605049 @default.
• W1976706183 creator A5071577552 @default.
• W1976706183 date "2013-12-01" @default.
• W1976706183 modified "2023-10-01" @default.
• W1976706183 title "Serpin B3 Is Associated with Poor Survival after Chemotherapy and Is a Potential Novel Predictive Biomarker in Advanced Non–Small-Cell Lung Cancer" @default.
• W1976706183 cites W1968077710 @default.
• W1976706183 cites W1971401701 @default.
• W1976706183 cites W1981976406 @default.
• W1976706183 cites W1996014231 @default.
• W1976706183 cites W1996109465 @default.
• W1976706183 cites W1999718696 @default.
• W1976706183 cites W2004718750 @default.
• W1976706183 cites W2013475220 @default.
• W1976706183 cites W2017439842 @default.
• W1976706183 cites W2018864565 @default.
• W1976706183 cites W2050957920 @default.
• W1976706183 cites W2060774265 @default.
• W1976706183 cites W2067896166 @default.
• W1976706183 cites W2070890790 @default.
• W1976706183 cites W2074459357 @default.
• W1976706183 cites W2078516546 @default.
• W1976706183 cites W2079913462 @default.
• W1976706183 cites W2088195015 @default.
• W1976706183 cites W2107183277 @default.
• W1976706183 cites W2110468894 @default.
• W1976706183 cites W2113499049 @default.
• W1976706183 cites W2118587530 @default.
• W1976706183 cites W2119366998 @default.
• W1976706183 cites W2121110745 @default.
• W1976706183 cites W2124392685 @default.
• W1976706183 cites W2124767044 @default.
• W1976706183 cites W2126290257 @default.
• W1976706183 cites W2135449612 @default.
• W1976706183 cites W2135836212 @default.
• W1976706183 cites W2139248078 @default.
• W1976706183 cites W2165112400 @default.
• W1976706183 cites W2168628406 @default.
• W1976706183 cites W2171215167 @default.
• W1976706183 cites W2171381573 @default.
• W1976706183 cites W2626223149 @default.
• W1976706183 cites W4231647528 @default.
• W1976706183 cites W4375906069 @default.
• W1976706183 doi "https://doi.org/10.1097/jto.0000000000000016" @default.
• W1976706183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24389432" @default.
• W1976706183 hasPublicationYear "2013" @default.
• W1976706183 type Work @default.
• W1976706183 sameAs 1976706183 @default.
• W1976706183 citedByCount "8" @default.
• W1976706183 countsByYear W19767061832016 @default.
• W1976706183 countsByYear W19767061832017 @default.
• W1976706183 countsByYear W19767061832018 @default.
• W1976706183 countsByYear W19767061832019 @default.
• W1976706183 countsByYear W19767061832022 @default.
• W1976706183 countsByYear W19767061832023 @default.
• W1976706183 crossrefType "journal-article" @default.
• W1976706183 hasAuthorship W1976706183A5038925845 @default.
• W1976706183 hasAuthorship W1976706183A5045865889 @default.
• W1976706183 hasAuthorship W1976706183A5049882275 @default.
• W1976706183 hasAuthorship W1976706183A5051588878 @default.
• W1976706183 hasAuthorship W1976706183A5055057910 @default.
• W1976706183 hasAuthorship W1976706183A5056605049 @default.
• W1976706183 hasAuthorship W1976706183A5071577552 @default.
• W1976706183 hasBestOaLocation W19767061831 @default.
• W1976706183 hasConcept C126322002 @default.
• W1976706183 hasConcept C143998085 @default.
• W1976706183 hasConcept C185592680 @default.
• W1976706183 hasConcept C204232928 @default.
• W1976706183 hasConcept C207103383 @default.
• W1976706183 hasConcept C2776256026 @default.
• W1976706183 hasConcept C2776694085 @default.
• W1976706183 hasConcept C2781197716 @default.
• W1976706183 hasConcept C44249647 @default.
• W1976706183 hasConcept C50382708 @default.
• W1976706183 hasConcept C55493867 @default.
• W1976706183 hasConcept C71924100 @default.
• W1976706183 hasConcept C90924648 @default.
• W1976706183 hasConceptScore W1976706183C126322002 @default.
• W1976706183 hasConceptScore W1976706183C143998085 @default.
• W1976706183 hasConceptScore W1976706183C185592680 @default.
• W1976706183 hasConceptScore W1976706183C204232928 @default.
• W1976706183 hasConceptScore W1976706183C207103383 @default.
• W1976706183 hasConceptScore W1976706183C2776256026 @default.
• W1976706183 hasConceptScore W1976706183C2776694085 @default.
• W1976706183 hasConceptScore W1976706183C2781197716 @default.
• W1976706183 hasConceptScore W1976706183C44249647 @default.
• W1976706183 hasConceptScore W1976706183C50382708 @default.
• W1976706183 hasConceptScore W1976706183C55493867 @default.
• W1976706183 hasConceptScore W1976706183C71924100 @default.
• W1976706183 hasConceptScore W1976706183C90924648 @default.
• W1976706183 hasIssue "12" @default.
• W1976706183 hasLocation W19767061831 @default.

• next